Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Madrigal Pharmaceuticals
Biotech
Viking's MASH drug scores where Madrigal's didn't
Viking executives were mum on exactly what a MASH drug's future will be given the competitive landscape, which disappointed investors.
Annalee Armstrong
Jun 4, 2024 1:51pm
John Cox gets new biotech CEO gig at Dyne—Chutes & Ladders
Mar 29, 2024 9:30am
Chinese biotech's MASH drug reduces liver fat in phase 2 trial
Mar 18, 2024 11:07am
As Madrigal lands MASH nod, what's next for biotechs in pursuit?
Mar 15, 2024 10:55am
Ionis raises hand in MASH race, shows liver gains in ph. 2 test
Mar 13, 2024 9:54am
Hepion’s NASH trial hangs in balance amid cost-cutting, CEO exit
Dec 7, 2023 11:38am
